Cargando…

Type 2 Diabetes: A Risk Factor for Hospital Readmissions and Mortality in Australian Patients With Cirrhosis

Although there is evidence that type 2 diabetes mellitus (T2D) impacts adversely on liver‐related mortality, its influence on hospital readmissions and development of complications in patients with cirrhosis, particularly in alcohol‐related cirrhosis (the most common etiological factor among Austral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Sang Bong, Powell, Elizabeth E., Russell, Anthony, Hartel, Gunter, Irvine, Katharine M., Moser, Chris, Valery, Patricia C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471423/ https://www.ncbi.nlm.nih.gov/pubmed/32923832 http://dx.doi.org/10.1002/hep4.1536

Ejemplares similares

Hospitalisation for cirrhosis in Australia: disparities in presentation and outcomes for Indigenous Australians
por: Valery, Patricia C., et al.
Publicado: (2020)

Increasing Hospitalization Rates for Cirrhosis: Overrepresentation of Disadvantaged Australians
por: Powell, Elizabeth E., et al.
Publicado: (2019)

Bacteraemia, sepsis and antibiotic resistance in Australian patients with cirrhosis: a population-based study
por: Johnson, Amy L, et al.
Publicado: (2021)

Disparities in Unmet Needs in Indigenous and Non-Indigenous Australians with Cirrhosis: An Exploratory Study
por: Bernardes, Christina M, et al.
Publicado: (2021)

ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies
por: Hayward, Kelly L, et al.
Publicado: (2020)

Assessment of health‐related quality of life and health utilities in Australian patients with cirrhosis
por: McPhail, Steven M, et al.
Publicado: (2020)

Predictors of Three-month Hospital Readmissions and Mortality in Patients with Cirrhosis of Liver
por: Lavekar, Anurag, et al.
Publicado: (2019)

Low Prevalence of Use of Allied Health and Community Services for Patients with Cirrhosis in Australia: A Need for Greater Engagement
por: Powell, Elizabeth E, et al.
Publicado: (2023)

Epidemiology of ascites fluid infections in patients with cirrhosis in Queensland, Australia from 2008 to 2017: A population-based study
por: Ratnasekera, Isanka U., et al.
Publicado: (2022)

Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Remoteness of residence predicts tumor stage, receipt of treatment, and mortality in patients with hepatocellular carcinoma
por: Taye, Belaynew W, et al.
Publicado: (2021)

Higher levels of supportive care needs are linked to higher health service use and cost, poor quality of life, and high distress in patients with cirrhosis in Queensland, Australia
por: Valery, Patricia C., et al.
Publicado: (2023)

Corrigendum: Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
por: Hayward, Kelly L., et al.
Publicado: (2016)

Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study
por: Valery, Patricia C., et al.
Publicado: (2022)

Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC)
por: Valery, Patricia C, et al.
Publicado: (2020)

Predicting Liver‐Related Outcomes in People With Nonalcoholic Fatty Liver Disease: The Prognostic Value of Noninvasive Fibrosis Tests
por: Johnson, Amy L., et al.
Publicado: (2021)

Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis
por: Essam Behiry, Mervat, et al.
Publicado: (2019)

Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis
por: Ebhohon, Ebehiwele, et al.
Publicado: (2021)

Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2022)

Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database
por: Garg, Sushil Kumar, et al.
Publicado: (2021)

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis
por: Graupera, Isabel, et al.
Publicado: (2016)

The Patient’s Perspective in Cirrhosis: Unmet Supportive Care Needs Differ by Disease Severity, Etiology, and Age
por: Valery, Patricia C., et al.
Publicado: (2021)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
por: Hayward, Kelly L., et al.
Publicado: (2021)

Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial
por: Hayward, Kelly L., et al.
Publicado: (2017)

Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2020)

Incidence and cost analysis of hospital admission and 30‐day readmission among patients with cirrhosis
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2018)

Factors influencing early and late readmissions in Australian hospitalised patients and investigating role of admission nutrition status as a predictor of hospital readmissions: a cohort study
por: Sharma, Yogesh, et al.
Publicado: (2018)

Reducing readmissions in patients with cirrhosis: the time to act is now
por: Patel, Arpan, et al.
Publicado: (2021)

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
por: Hayward, Kelly L, et al.
Publicado: (2017)

Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions
por: Kichloo, Asim, et al.
Publicado: (2021)

Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients
por: Jiang, Ting-Ting, et al.
Publicado: (2021)

Risk Factors for Frequent Readmissions and Barriers to Transplantation in Patients with Cirrhosis
por: Ganesh, Swaytha, et al.
Publicado: (2013)

Association of Hospital Discharge Against Medical Advice With Readmission and In-Hospital Mortality
por: Tan, Sally Y., et al.
Publicado: (2020)

Readmission and hospital mortality after ICU discharge of critically ill cancer patients
por: Jeong, Byeong-Ho, et al.
Publicado: (2019)

Risk of Readmission and Mortality Following Hospitalization with Hypercapnic Respiratory Failure
por: Meservey, Amber J., et al.
Publicado: (2019)

Time to hospital discharge and subsequent hospital readmission and mortality rates in icu survivors
por: Campbell, R, et al.
Publicado: (2015)

Correction: Readmission and hospital mortality after ICU discharge of critically ill cancer patients
por: Jeong, Byeong-Ho, et al.
Publicado: (2019)

Australian Injury Comorbidity Indices (AICIs) to predict burden and readmission among hospital-admitted injury patients
por: Fernando, Dasamal Tharanga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k7bc9egufpjalns1bv5aki8533